The following relates generally to the respiratory therapy arts, mechanical ventilation arts, mechanical ventilation control arts, endobronchial valve arts, and related arts.
Invasive mechanical ventilation is a key component of intensive care. Several different methods of ventilation exist, which differ in several variables: Ventilation can be distinguished by the way how a breath is triggered (pressure, volume, flow), by the limits (on volume, pressure, or flow) that should not be exceeded, and the cycle factors terminating an inspiration (again pressure, volume, flow, time). There exist volume-targeted ventilator modes, pressure targeted modes, as well as combined modes. An amount of Positive End-Expiratory Pressure (PEEP) is an important factor as well. The intensivist has thus many ventilation parameters at hand to optimally care for the individual patient.
However, all of these different ventilation modes and parameters provide air, pressure, volume, and flow via a single interface to the patient body: the trachea and therein an endotracheal tube (ETT) for invasive ventilation. The distribution of the insufflated air volume within the lung depends on the local airway resistance and the regional compliance of the respiratory system. In some diseases, one or both of the local airway resistance and the regional compliance are heterogenous, thus leading to heterogeneous distribution of the insufflated volume. This can lead to the situation that in some regions the PEEP value is too low for lung recruitment, while in other regions the pressure is too high and leads to lung overdistention or to cardiac complications. Examples are patients having lobar pneumonia, lobar atelectasis, or other asymmetrical pulmonary problems. Patients with e.g. ARDS (Acute Respiratory Distress Syndrome) often develop an edema, which due to gravity-induced pressure can lead to poorly inflated or collapsed pulmonary units of the dependent lung regions.
Inhomogeneous inflation or deflation of the lungs can also cause dynamic pressure differences between regions and lead to interregional airflows known as pendelluft (see, e.g., Elliot E. Greenblatt et al., ‘Pendelluft in the Bronchial Tree,’ Journal of Applied Physiology, 117.9 (2014), 979-88 https://doi.org/10.1152/japplphysiol.00466.2014). This may be an important phenomenon contributing to regional gas exchange, irreversible mixing, and aerosol deposition patterns inside poorly ventilated regions of the lung. It is more prominent in diseases with a significant heterogeneity in both resistance and compliance.
In addition, COPD (Chronic Obstructive Pulmonary Disease) is a progressive lung disease associated with emphysema. Emphysema is characterized by air-filled spaces in the lung and permanent damage to the lung tissue. Emphysematous parts of the lung can hyperinflate. In consequence, other healthier parts of the lung have less space in the thorax and can thus not participate adequately in gas exchange leading to shortness of breath. Therefore, the surgical removal of the lobe most affected by emphysema (lung volume reduction surgery) can be an effective treatment for severe COPD.
The implantation of endobronchial valves is a minimally-invasive alternative to lung volume reduction surgery and is also called Bronchoscopic Lung Volume Reduction (BLVR). One or more endobronchial valves are placed bronchoscopically (i.e. under visual control) in one or more bronchi. These valves are simple one-way valves, which allow the air to be breathed out, but not breathed in. After implantation, the target lobe rapidly collapses (if there is no pulmonary shunt) and gives space to more healthy lobes. Several valve systems are on the market (e.g., from Olympia Spiration, Pulmonx, and so forth). Endobronchial valves can easily be placed and removed again with a dedicated catheter through the working channel of the bronchoscope.
As such, there are many situations in intensive care, in which it would be favorable that a ventilated patient could get regionally targeted ventilation volume. However, it is not possible with current ventilation systems to locally measure the pressure, flow, or volume reaching a subunit of the lung (e.g. a lobe or a segment). It is also not possible to target parts of the lung with a dedicated parameter setting (e.g. pressure, volume, or flow) or with a dedicated pressure, flow, or volume curve.
The following discloses certain improvements to overcome these problems and others.
In one aspect, a medical device for treating an associated patient includes a bronchial sensor device configured to measure fluid pressure in a bronchus of the associated patient; and an electronic controller configured to: receive the fluid pressure data from the bronchial sensor device; and calculate a fluid flow measurement through the bronchus based on the measured fluid pressure.
In another aspect, a medical device for treating an associated patient includes a bronchial sensor device for placement in a bronchus of the associated patient and configured to measure fluid pressure in the bronchus. The bronchial sensor device includes a base; a membrane connected to the base; and a micro-bot actuator connected to the membrane. An electronic controller is configured to receive the fluid pressure data from the bronchial sensor device; and calculate a fluid flow measurement through the bronchus based on a distance between the membrane and the base measured by the micro-bot actuator.
One advantage resides in providing patients undergoing mechanical ventilation therapy with a regionally targeted ventilation volume.
Another advantage resides in providing a mechanical ventilation system that can locally measure pressure, flow, or volume reaching a subunit of the lung.
Another advantage resides in targeting parts of a lung with a dedicated parameter setting (e.g. pressure, volume, or flow) or with a dedicated pressure, flow, or volume curve for a patient undergoing mechanical ventilation therapy.
Another advantage resides in automatically adjusting settings of a mechanical ventilator to help wean patients off mechanical ventilation therapy.
A given embodiment may provide none, one, two, more, or all of the foregoing advantages, and/or may provide other advantages as will become apparent to one of ordinary skill in the art upon reading and understanding the present disclosure.
The disclosure may take form in various components and arrangements of components, and in various steps and arrangements of steps. The drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the disclosure.
As used herein, the singular form of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise. As used herein, statements that two or more parts or components are “coupled,” “connected,” or “engaged” shall mean that the parts are joined, operate, or co-act together either directly or indirectly, i.e., through one or more intermediate parts or components, so long as a link occurs. Directional phrases used herein, such as, for example and without limitation, top, bottom, left, right, upper, lower, front, back, and derivatives thereof, relate to the orientation of the elements shown in the drawings and are not limiting upon the scope of the claimed invention unless expressly recited therein. The word “comprising” or “including” does not exclude the presence of elements or steps other than those described herein and/or listed in a claim. In a device comprised of several means, several of these means may be embodied by one item of hardware.
In order to provide a regional measurement of ventilation parameters for a patient undergoing mechanical ventilation therapy, one or more measurement devices are placed endobronchially (i.e. with the help of a bronchoscope) in one or more of the lobar bronchi or segmental bronchi or even smaller bronchi. The measurement device is placed and fixed endobronchially. It contains one or more pressure sensors, preferably based on Micro-Bot technology (see, e.g., J Rahmer, C Stehning, and B Gleich, ‘Spatially Selective Remote Magnetic Actuation of Identical Helical Micromachines.,’ Science Robotics, 2.3 (2017)), which can be read out wirelessly and do not need a built-in power supply (see, e.g., US 2021/0244305, which is incorporated herein in its entirety by reference). The measurement device is based on Bernoulli's principle and the configuration of the pressure sensors in the measurement device depends on the physical quantity to be measured, e.g. pressure and flow. Typically, the measurement device has some sort of known constriction, which adds a defined resistor to the airflow. The pressure signal from the pressure sensors is read out and transmitted to a computer, which calculates regional e.g. time-pressure, time-flow, and time-volume curves. Alternatively, regional ventilation parameters can be assessed with the help of imaging devices.
In addition, ventilators can provide ventilation only via the trachea to the lungs in total. Thus, they can ventilate only with a single time-pressure or time-volume curve. To provide individual pressure, volume, or flow to different lung regions (lobes, segments, or even subsegmental regions), one or more control devices are placed endobronchially. These control devices can shape ventilation parameters like pressure, volume, or flow by adapting (typically increasing) the resistance of the airway or acting as a valve and fully closing the airway.
The control device contains one or more actuators, preferably based on Micro-Bot technology, which can be switched wirelessly without built-in power supply (see, e.g., Jurgen Rahmer, Christian Stehning, and Bernhard Gleich, ‘Remote Magnetic Actuation Using a Clinical Scale System,’ PLOS ONE, 13.3 (2018)). The switching or resistance change is controlled by a computer. This controller may work independently (sensing the ventilator actions), or may be digitally connected to the mechanical ventilator such that the timing and strength of valve actions are in synchrony with the ventilation.
As disclosed herein, in a preferred embodiment, a measurement device and a control device are combined in one device allowing to measure and shape regional ventilation parameters in real-time. The system can work in an open and a closed loop manner and can work continuously or intermittently. Both, measurement and control devices can be built based on Micro-Bot technology comprising magneto-mechanical oscillators, which enable building tiny (1-2 mm in length) wireless markers and sensors that can be interrogated remotely using magnetic fields. Micro-bots can be built such that physical quantities like pressure are influencing their oscillation frequency, which can be detected from the outside. They do not require a power supply and are thus ideal for the application of providing regional ventilation.
With reference to
The non-transitory computer readable medium 15 of the mechanical ventilator 2 stores instructions executable by the electronic controller 13 of the mechanical ventilator 2 perform a measurement method or process 100. To do so, the measurement method 100 performed by the electronic controller 13 includes receiving the fluid pressure data from the bronchial sensor device 10, and calculating a fluid flow measurement through the bronchus based on the measured fluid pressure. In one embodiment, an indication of the fluid flow measurement can be displayed on the display device 14 of the mechanical ventilator 2. In another embodiment, the fluid flow measurement can be input to the electronic controller 13 to control operation of the mechanical ventilator in delivery mechanical ventilation therapy to the patient P. For example, if the fluid flow measurement underruns a predetermined fluid flow threshold, the mechanical ventilator 2 can be controlled to provide additional air to the patient P. whereas if the fluid flow measurement is equal to or exceeds the predetermined fluid flow threshold, the mechanical ventilator 2 can be controlled to provide a lower quantity of air to the patient P.
The non-transitory computer readable medium 15 of the mechanical ventilator 2 optionally further stores instructions executable by the electronic controller 13 of the mechanical ventilator 2 perform a ventilation control method or process 100. To do so, the control method 200 performed by the electronic controller 13 includes the receiving of the fluid flow measurement calculated by the measurement process 100 and, based on that measurement along with other information such as settings of the mechanical ventilator 2, global ventilation flow measurements acquired by gas flow, pressure, etCO2, or other sensors of the ventilator 2 generates a control signal 21 for controlling the mechanical ventilation of the patient. In one example, at least one setting of the mechanical ventilator 2 is controlled based on the fluid flow measurement through the bronchus acquired by the method 100. For example, if the fluid flow measurement indicates that a portion of the lungs 18 may be receiving too much gas flow then the settings of the ventilator 2 may be adjusted to reduce the gas flow measured by the method 100 until it reaches a target level. In another example, if the gas flow measured by the method 100 is too high then the endobronchial valve 20 (which in this example may be in the same bronchus as the sensor 10) may be actuated to close (completely or partially, depending on the valve type), thereby reducing or eliminating the gas flow through that bronchus. In other examples, at least one setting of the mechanical ventilator 2 can be controlled based on one or more of the measured fluid pressure in the bronchus, the calculated fluid flow measurement through the bronchus, a determined volume of fluid in the bronchus, and other measured or derived parameters.
With reference successively to
Yet another method is a configuration similar to a pitot tube where one micro-bot pressure sensor is used to measure the stagnation (or total) pressure and another micro-bot pressure sensor measures the static pressure. From Bernouill's equation the flow velocity-dependent dynamic pressure, and hence the flow velocity, can be calculated.
With reference to
The endobronchial valve 20 is configured to block a region of the lung, by blocking a bronchial tube that ordinarily passes a portion of the air delivered by the mechanical ventilator 2 to that lung region. As shown in
In some embodiments, the bronchial sensor device 10 can include a membrane and an adjustable magneto-mechanical oscillator device with a simple gear mechanism that can be used to construct a valve which acts as a pressure regulator. This control device would adjust its opening automatically to limit the pressure to one or more portions of the lungs of the patient P. Once the measurement devices combined with control devices have been placed bronchoscopically in the bronchi, these devices are controlled in real-time with the help of a transceiver system to get signals to and from the magneto-mechanical oscillator devices. The signals from the measurement devices are analyzed with the help of a computer program, which calculates pressures, flows, and volumes. These values enter a model of the patient's lung either based on an individual CT scan or on the general knowledge of human anatomy.
The operator of the device 10 can adjust maximal pressure, maximal flow, maximal volume, etc. for each of the control devices in the lung regions of interest. In addition, the computer program controls the settings of a mechanical ventilator, which provides air pressure, flow, and volume through the trachea. Dynamic control of the devices is in particular interesting for handling dynamic ventilation problems like pendelluft by ensuring e.g. that air can flow only out during expiration and only in during inspiration.
As an example use case, alveolar overdistention is a condition which can lead to persistent lung damage after mechanical ventilation. To protect the lungs, a plateau pressure applied to small airways and alveoli during positive-pressure ventilation should be limited. The bronchial sensor device 10 allows for clinicians to measure the local pressure within one or more bronchi B of the patient P.
Since a local pressure is not necessarily the same as the pressure applied by the mechanical ventilator 2 at the endotracheal tube 16, local pressure measurements can be used to limit the local plateau pressure, for example, by changing the overall settings of the mechanical ventilator 2 in such a way that the overall plateau pressure at the endotracheal tube 16 is reduced. With this approach, not only the average plateau pressure (as measured by the mechanical ventilator 2), but also the local plateau pressures, do not exceed a predetermined threshold. For example, the maximum of the local pressure measurements can be used determine the optimal overall pressure by adapting the actual overall pressure (increasing or decreasing) until the maximum of the local pressure measurements has a certain target value.
Instead of measuring the local pressure, it is also possible to measure the local flow and (for example, by integrating flow over time) to measure the local tidal volume using the bronchial sensor device 10. Therefore, for each of the lung areas equipped with a bronchial sensor device 10 in the corresponding bronchus B, it is possible to measure the local tidal volume. If the local tidal volume exceeds a predetermined threshold, the overall tidal volume as applied by the mechanical ventilator 2 may be reduced until all measured local tidal volumes are below their thresholds.
To protect the lungs from local alveolar overdistention, one or more endobronchial valves 20 may be placed endobronchially in different bronchi B. These endobronchial valves 20 may contain the micro-bot actuators 54 configured to close a corresponding bronchus B triggered by an external signal applied to the micro-bot actuators 54. In addition, the endobronchial valves 20 may contain one or more micro-bot sensors 32,34 which measure local pressure and local flow.
The optimal local tidal volumes corresponding to the lung areas controlled by the endobronchial valves 20 may be determined based on a computed tomography (CT) scan or a digital model of a lung of the patient P. These optimal local tidal volumes are portions (i.e., percentages) of the overall tidal volume that the mechanical ventilator 2 delivers at the endotracheal tube 16. If the overall tidal volume is increased or decreased, these optimal local tidal volumes also change proportionally.
If during an inspiration the volume measurement at one of the endobronchial valves 20 exceeds the optimal local tidal volume, the micro-bot actuator 54 is triggered to close the endobronchial valve 20. Thereafter, a remainder of the overall tidal volume as delivered by the mechanical ventilator 2 would be distributed to the other lung areas, which have not reached their optimal tidal volume yet. The procedure would be repeated with the rest of the endobronchial valves 20 until, at the end of the inspiration (i.e., when the overall tidal volume is delivered by the mechanical ventilator 2), all lung areas behind the endobronchial valves 20 will have received their optimal tidal volume.
In some embodiments, instead of implanting active control devices, passive resistors or valves can be used. For example, passive resistors are simple stents with constrictions of a defined diameter. They can either be built with fixed diameter, and the resistor with the right diameter must be selected. Alternatively, resistors with adjustable constriction (and thus adjustable resistance) can be built. Their properties are set before implantation and as passive devices remain fixed until they are explanted. In another example, passive valves are similar to passive resistors. They open and close at a fixed (or adjustable and then fixed) pressure or flow.
In some embodiments, a computer program (e.g. a model comprising a Digital Twin of the patient) can be used to estimate the optimal selection or settings of the passive control devices.
In some embodiments, feedback can be provided to a clinician, such as feedback from functional imaging to adapt the control devices and/or feedback from wearables or patient monitors (e.g. vital sign measuring devices) to adapt the control devices.
The disclosure has been described with reference to the preferred embodiments. Modifications and alterations may occur to others upon reading and understanding the preceding detailed description. It is intended that the exemplary embodiment be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
This patent application claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 63/346,341, filed on May 27, 2022, the contents of which are herein incorporated by reference.
Number | Date | Country | |
---|---|---|---|
63346341 | May 2022 | US |